0000000000667954

AUTHOR

Francesco Romano

0000-0003-3829-3139

showing 6 related works from this author

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?

2021

Antiphospholipid syndrome (APS) is frequently associated with thrombocytopenia, in most cases mild and in the absence of major bleedings. In some patients with a confirmed APS diagnosis, secondary immune thrombocytopenia (ITP) may lead to severe thrombocytopenia with consequent major bleeding. At the same time, the presence of antiphospholipid antibodies (aPL) in patients with a diagnosis of primary ITP has been reported in several studies, although with some specific characteristics especially related to the variety of antigenic targets. Even though it does not enter the APS defining criteria, thrombocytopenia should be regarded as a warning sign of a “high risk” APS and thus thoroughly ev…

Pediatricsmedicine.medical_specialtyQH301-705.5medicine.drug_classMedicine (miscellaneous)thrombocytopeniaReviewGeneral Biochemistry Genetics and Molecular BiologyAntigenimmune system diseasesAntiphospholipid syndromehemic and lymphatic diseasesmedicineBiology (General)Antiphospholipid antibodies Antiphospholipid syndrome Immune thrombocytopenia Lupus anticoagulant ThrombocytopeniaLupus anticoagulantbiologybusiness.industryAnticoagulantantiphospholipid antibodiesmedicine.diseaseThrombosisImmune thrombocytopeniaVenous thrombosislupus anticoagulantimmune thrombocytopeniabiology.proteinAntibodybusinessAntiphospholipid antibodieantiphospholipid syndromeBiomedicines
researchProduct

Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D'Amato et al

2021

We have read with interest the letter from D’Amato et al. entitled “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations”....

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryHome therapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19030204 cardiovascular system & hematologyLMWH03 medical and health sciences0302 clinical medicinemedicineSteroidsbusinessLetter to the EditorHome therapy030215 immunology
researchProduct

The FIRST experiment at GSI

2012

The FIRST (Fragmentation of Ions Relevant for Space and Therapy) experiment at the SIS accelerator of GSI laboratory in Darmstadt has been designed for the measurement of ion fragmentation cross-sections at different angles and energies between 100 and 1000 MeV/nucleon. Nuclear fragmentation processes are relevant in several fields of basic research and applied physics and are of particular interest for tumor therapy and for space radiation protection applications. The start of the scientific program of the FIRST experiment was on summer 2011 and was focused on the measurement of 400 MeV/nucleon 12C beam fragmentation on thin (8 mm) graphite target. The detector is partly based on an alread…

Nuclear and High Energy PhysicsIon beamPhysics::Instrumentation and Detectorsmedicine.medical_treatmentNuclear physics[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]ScintillatorElementary-particleFIRST7. Clean energy01 natural sciencesParticle detectorWire chamberNuclear physicsDipole magnetFragmentationPARTICLE THERAPYhadrontherapy; fragmentation; nuclear physics; elementary-particle; instrumentation; experimental methodsHadrontherapy0103 physical sciencesmedicineNeutron detectionddc:530Gaseous detectorION-BEAM010306 general physicsNuclear ExperimentDETECTORInstrumentationGEANT4PARTICLE THERAPY; FLUKA CODE; ION-BEAM; FRAGMENTATION; BENCHMARKING; RADIOTHERAPY; TRANSPORT; DETECTOR; GEANT4; FIRSTPhysicsParticle therapyTime projection chamber010308 nuclear & particles physicsExperimental methodsDetectorScintillatorTRANSPORTSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Hadrontherapy; Fragmentation; Nuclear physics; Elementary-particle; Experimental methods; InstrumentationFLUKA CODEBENCHMARKINGElementary-particle; Experimental methods; Fragmentation; Hadrontherapy; Instrumentation; Nuclear physics; Instrumentation; Nuclear and High Energy PhysicsRADIOTHERAPY
researchProduct

First Characterization of Novel Silicon Carbide Detectors with Ultra-High Dose Rate Electron Beams for FLASH Radiotherapy

2023

Ultra-high dose rate (UHDR) beams for FLASH radiotherapy present significant dosimetric challenges. Although novel approaches for decreasing or correcting ion recombination in ionization chambers are being proposed, applicability of ionimetric dosimetry to UHDR beams is still under investigation. Solid-state sensors have been recently investigated as a valuable alternative for real-time measurements, especially for relative dosimetry and beam monitoring. Among them, Silicon Carbide (SiC) represents a very promising candidate, compromising between the maturity of Silicon and the robustness of diamond. Its features allow for large area sensors and high electric fields, required to avoid ion r…

FLASH radiotherapy; Silicon Carbide; dosimetry; beam monitoring; UHDRFluid Flow and Transfer Processesbeam monitoringdosimetrySilicon CarbidePhysicsProcess Chemistry and TechnologyGeneral EngineeringSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Computer Science ApplicationsChemistryUHDRFLASH radiotherapyGeneral Materials ScienceHuman medicineInstrumentationApplied Sciences (Switzerland)
researchProduct

Immunoistochemical expression of PD-1 and PD-L1 in bone marrow biopsies of patients with acute myeloid leukemia

2020

Background. Haematological and non-haematological malignancies are able to escape the host immune by the capacity to hijack the immune check-points. Several immune check-point molecules are known, such as T cell immunoglobulin mucin-3 (TIM-3), cytotoxic T-cell antigen-4 (CTLA-4), programmed death-1 (PD-1) with its ligand PD-L1 and others.1 The function of these immune check-points is to prevent the damage resulting from an excessive activation of the immune response in the setting of chronic antigenic stimulation, thus leading to autoimmune phenomena, as proved in knock-out mice models. PD-1 is normally present on activated T lymphocytes membrane, acting as a negative costimulatory receptor…

0301 basic medicinemedicine.medical_treatmentvirusesanimal diseaseschemical and pharmacologic phenomena03 medical and health sciences0302 clinical medicinePD-L1Medicinebiologybusiness.industrylcsh:RC633-647.5Myeloid leukemiaHematologyImmunotherapylcsh:Diseases of the blood and blood-forming organsAcute myeloid leukemia Immune check-point blockade Immunotherapy PD-1 PD-L1biochemical phenomena metabolism and nutritionacute myeloid leukemia; immune check-point blockade; PD-1; PD-L1; immunotherapy030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisCancer researchbiology.proteinbacteriaBone marrowbusinessHematology Reports
researchProduct

FIRST experiment: Fragmentation of Ions Relevant for Space and Therapy

2013

International audience; Nuclear fragmentation processes are relevant in different fields of basic research and applied physics and are of particular interest for tumor therapy and for space radiation protection applications. The FIRST (Fragmentation of Ions Relevant for Space and Therapy) experiment at SIS accelerator of GSI laboratory in Darmstadt, has been designed for the measurement of different ions fragmentation cross sections at different energies between 100 and 1000 MeV/nucleon. The experiment is performed by an international collaboration made of institutions from Germany, France, Italy and Spain. The experimental apparatus is partly based on an already existing setup made of the …

HistorySilicon detectorApplied physicsPhysics::Instrumentation and DetectorsScintillator[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]7. Clean energy01 natural sciencesSpace radiation030218 nuclear medicine & medical imagingEducationIonExperimental apparatuNuclear physics03 medical and health sciencesPhysics and Astronomy (all)0302 clinical medicineFragmentation (mass spectrometry)0103 physical sciencesNeutron detectionddc:530Silicon Vertex DetectorIon010306 general physicsNuclear ExperimentScintillation counterRadiation protectionPhysicsDetectorNuclear fragmentationComputer Science ApplicationsInternational collaborationProtection applicationMagnet[PHYS.PHYS.PHYS-MED-PH]Physics [physics]/Physics [physics]/Medical Physics [physics.med-ph]Scientific programInternational cooperationNucleonInteraction region
researchProduct